Bioethics Panels Open Door Slightly to Germline Gene Editing
By Jeff Lyon,
JAMA
| 10. 18. 2017
As CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats–Cas9) and other gene-editing technologies hasten the feasibility of effective somatic and germline genomic manipulation, an international panel of genetics groups has weighed in on some of the thorniest ethical and scientific implications facing clinical use of gene editing.
Led by the American Society of Human Genetics (ASHG), 11 organizations published a joint statement in August concentrating on the prospects for germline alteration, a no-fly zone among molecular biologists since the dawn of gene therapy in the 1980s. The ASHG-sponsored statement was drafted by a committee of representatives from the UK Association of Genetic Nurses and Counsellors, Canadian Association of Genetic Counsellors, the International Genetic Epidemiological Society, and the US National Society of Genetic Counselors, as well as the ASHG. The final document was endorsed by these groups and 6 other international medical or genetics associations.
The new statement does not rule out the eventual therapeutic editing of human DNA in ways that could be passed along to later generations: “Currently, there is no reason to prohibit in vitro germline genome editing on...
Related Articles
By Isabelle Bartram
| 07.17.2024
Image by Kuzzat Altay from Unsplash
Uyghurs, a predominantly Muslim minority in China, are mainly located in the autonomous region of Xinjiang. The Chinese government has pursued an aggressive settlement policy in this region since 1949, with the percentage of Han Chinese in the region increasing from five to forty percent in the second half of the 20th century. Since 2014, the Uyghurs have been subject to persecution and re-education – various sources have estimated that at least one million...
By Emma McDonald Kennedy
| 07.11.2024
Louise Perry’s recent article in The Spectator cautions against “The quiet return of eugenics,” a threat she locates in preimplantation genetic testing for polygenic disorders. The technology is billed as a way for parents undergoing IVF to select which embryo to implant based on information about each embryo’s genetic risk factors and traits. These reports, she says, give parents “a very full picture of the adult that embryo could become”––from their child’s risk of developing different diseases to their “likely...
GATTACA was released in 1997, but — remarkably — is even more relevant now than it was then, as the technologies whose social implications it explores have developed considerably.
On Thursday, June 13, the California Film Institute presented GATTACA to a sold-out house at the Christopher B. Smith Rafael Film Center as part of their Science on Screen series. CGS Associate Director Katie Hasson offered framing for the film and participated in a Q+A discussion.
The film’s plot explicitly involves...